Showing results (1071-1080 of 1,129) with videos related to

Sort By:
Pageof 113
American Journal of Hematology|November 16, 2024
A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre-transplantation for Ph+ acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort studyHui Liu, Hui Xu, Peiru Chi, et al.
Bone Marrow Transplantation|August 30, 2022
Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remissionHan-Zhou Qi, Jun Xu, Qian-Qian Yang, et al.
Iscience|November 9, 2023
Prognostic significance of inflammation in patients with coronary artery disease at low residual inflammatory riskTianyu Li, Peizhi Wang, Xiaozeng Wang, et al.
Viruses|April 26, 2016
Intranasal Immunization with Influenza Virus-Like Particles Containing Membrane-Anchored Cholera Toxin B or Ricin Toxin B Enhances Adaptive Immune Responses and Protection against an Antigenically Distinct VirusXianliang Ji, Zhiguang Ren, Na Xu, et al.
Scientific Reports|November 26, 2024
Effect of high sensitivity C-reactive protein on uric acid-related cardiometabolic risk in patients with coronary artery disease-a large multicenter prospective studyYing Song, Weiting Cai, Lin Jiang, et al.
Biomarker Research|August 20, 2025
Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantationZhonghui Jiang, Ya Zhou, Yuxin Bai, et al.
Frontiers in Endocrinology|June 6, 2022
Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary InterventionXiao-Fang Tang, Chen He, Pei Zhu, et al.
Journal of Hematology & Oncology|April 20, 2016
Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemiaNa Xu, Yu-ling Li, Xuan Li, et al.
Cancer Medicine|July 6, 2023
Quality-of-life, mental health, and perspective on TKI dose reduction as a prelude to discontinuation in chronic phase chronic myeloid leukemiaYilin Chen, Na Xu, Yunfan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN LossJohann S de Bono, Ugo De Giorgi, Daniel Nava Rodrigues, et al.
Pageof 113